The role of gut microbiota in patients with benign and malignant brain tumors: a pilot study

References

• Ostrom QT, Patil N, Cioffi G, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017. Neuro Oncol. 2020;22(12 Suppl 2):iv1–iv96.
   PubMed Web of Science ®Google Scholar
• Wang L, Chen S, Liu Y, et al. The biological and diagnostic roles of MicroRNAs in meningiomas. Rev Neurosci. 2020;31(7):771–778.
   PubMed Web of Science ®Google Scholar
• Bachir S, Shah S, Shapiro S, et al. Neurofibromatosis Type 2 (NF2) and the implications for vestibular schwannoma and meningioma pathogenesis. Int J Mol Sci. 2021;22(2):690.
   PubMed Web of Science ®Google Scholar
• Low SS, Ji D, Chai WS, et al. Recent progress in nanomaterials modified electrochemical biosensors for the detection of MicroRNA. Micromachines (Basel). 2021;12(11). DOI:10.3390/mi12111409.
   PubMed Web of Science ®Google Scholar
• Low SS, Pan YX, Ji DZ, et al. Smartphone-based portable electrochemical biosensing system for detection of circulating microRNA-21 in saliva as a proof-of-concept. Sens Actuat B-Chem. 2020;308:127718.
   Web of Science ®Google Scholar
• Ostrom QT, Adel Fahmideh M, Cote DJ, et al. Risk factors for childhood and adult primary brain tumors. Neuro Oncol. 2019;21(11):1357–1375.
   PubMed Web of Science ®Google Scholar
• Zhao L, Ye Y, Gu L, et al. Extracellular vesicle-derived miRNA as a novel regulatory system for bi-directional communication in gut-brain-microbiota axis. J Transl Med. 2021;19(1):202.
   PubMed Web of Science ®Google Scholar
• Dehhaghi M, Kazemi Shariat Panahi H, Heng B, et al. The gut microbiota, kynurenine pathway, and immune system interaction in the development of brain cancer. Front Cell Dev Biol. 2020;8:562812.
   PubMed Web of Science ®Google Scholar
• Petrella C, Farioli-Vecchioli S, Cisale GY, et al. A healthy gut for a healthy brain: preclinical, clinical and regulatory aspects. Curr Neuropharmacol. 2021;19(5):610–628.
   PubMed Web of Science ®Google Scholar
• Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55–71.
   PubMed Web of Science ®Google Scholar
• He T, Cheng X, Xing C. The gut microbial diversity of colon cancer patients and the clinical significance. Bioengineered. 2021;12(1):7046–7060.
   PubMed Web of Science ®Google Scholar
• Zhang X, Coker OO, Chu ES, et al. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. Gut. 2021;70(4):761–774.
   PubMed Web of Science ®Google Scholar
• How CW, Ong YS, Low SS, et al. How far have we explored fungi to fight cancer? Semin Cancer Biol. 2021. DOI:10.1016/j.semcancer.2021.03.009.
   PubMed Web of Science ®Google Scholar
• Lyu Y, Yang H, Chen L. Metabolic regulation on the immune environment of glioma through gut microbiota. Semin Cancer Biol. 2021. DOI:10.1016/j.semcancer.2021.05.005
   PubMedGoogle Scholar
• D’Alessandro G, Lauro C, Quaglio D, et al. Neuro-signals from gut microbiota: perspectives for brain glioma. Cancers (Basel). 2021;13(11):2810.
   PubMed Web of Science ®Google Scholar
• Patrizz A, Dono A, Zorofchian S, et al. Glioma and temozolomide induced alterations in gut microbiome. Sci Rep. 2020;10(1):21002.
   PubMed Web of Science ®Google Scholar
• Li XC, Wu BS, Jiang Y, et al. Temozolomide-induced changes in gut microbial composition in a mouse model of brain glioma. Drug Des Devel Ther. 2021;15:1641–1652.
   PubMed Web of Science ®Google Scholar
• Wen Y, Feng L, Wang H, et al. Association between oral microbiota and human brain glioma grade: a case-control study. Front Microbiol. 2021;12:746568.
   PubMed Web of Science ®Google Scholar
• Hou W, Li J, Cao Z, et al. Decorating bacteria with a therapeutic nanocoating for synergistically enhanced biotherapy. Small. 2021;17(37):e2101810.
   PubMed Web of Science ®Google Scholar
• Yang P, Wang Z, Peng Q, et al. Comparison of the gut microbiota in patients with benign and malignant breast tumors: a pilot study. Evol Bioinform Online. 2021;17:11769343211057573.
   Web of Science ®Google Scholar
• Jiang W, Wang T, Liu C, et al. A 16S rRNA gene sequencing based study of oral microbiota in migraine patients in China. Bioengineered. 2021;12(1):2523–2533.
   PubMed Web of Science ®Google Scholar
• Wagner Mackenzie B, Waite DW, Taylor MW. Evaluating variation in human gut microbiota profiles due to DNA extraction method and inter-subject differences. Front Microbiol. 2015;6:130.
   PubMed Web of Science ®Google Scholar
• Li N, Yang J, Zhang J, et al. Correlation of gut microbiome between ASD children and mothers and potential biomarkers for risk assessment. Genomics Proteomics Bioinformatics. 2019;17(1):26–38.
   PubMed Web of Science ®Google Scholar
• Lozupone CA, Knight R. Species divergence and the measurement of microbial diversity. FEMS Microbiol Rev. 2008;32(4):557–578.
   PubMed Web of Science ®Google Scholar
• Shi Y, Zhang L, Do KA, et al. aPCoA: covariate adjusted principal coordinates analysis. Bioinformatics. 2020;36(13):4099–4101.
   PubMed Web of Science ®Google Scholar
• Zhu C, Yu J. Nonmetric multidimensional scaling corrects for population structure in association mapping with different sample types. Genetics. 2009;182(3):875–888.
   PubMed Web of Science ®Google Scholar
• Salaheen S, Kim SW, Hovingh E, et al. Metagenomic analysis of the microbial communities and resistomes of veal calf feces. Front Microbiol. 2020;11:609950.
   PubMed Web of Science ®Google Scholar
• Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60.
   PubMed Web of Science ®Google Scholar
• Langille MG, Zaneveld J, Caporaso JG, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013;31(9):814–821.
   PubMed Web of Science ®Google Scholar
• Parks DH, Beiko RG. Identifying biologically relevant differences between metagenomic communities. Bioinformatics. 2010;26(6):715–721.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhao L, Han L, et al. The differential distribution of bacteria between cancerous and noncancerous ovarian tissues in situ. J Ovarian Res. 2020;13(1):8.
   PubMed Web of Science ®Google Scholar
• Morais LH, Schreiber HLT, Mazmanian SK. The gut microbiota-brain axis in behaviour and brain disorders. Nat Rev Microbiol. 2021;19(4):241–255.
   PubMed Web of Science ®Google Scholar
• Ge Y, Wang X, Guo Y, et al. Gut microbiota influence tumor development and Alter interactions with the human immune system. J Exp Clin Cancer Res. 2021;40(1):42.
   PubMed Web of Science ®Google Scholar
• Yang HT, Xiu WJ, Liu JK, et al. Gut microbiota characterization in patients with asymptomatic hyperuricemia: probiotics increased. Bioengineered. 2021;12(1):7263–7275.
   PubMed Web of Science ®Google Scholar
• Rüb AM, Tsakmaklis A, Gräfe SK, et al. Biomarkers of human gut microbiota diversity and dysbiosis. Biomark Med. 2021;15(2):137–148.
   PubMed Web of Science ®Google Scholar
• Yu B, Qiu H, Cheng S, et al. Profile of gut microbiota in patients with traumatic thoracic spinal cord injury and its clinical implications: a case-control study in a rehabilitation setting. Bioengineered. 2021;12(1):4489–4499.
   PubMed Web of Science ®Google Scholar
• D’Alessandro G, Antonangeli F, Marrocco F, et al. Gut microbiota alterations affect glioma growth and innate immune cells involved in tumor immunosurveillance in mice. Eur J Immunol. 2020;50(5):705–711.
   PubMed Web of Science ®Google Scholar
• Liu F, Li J, Guan Y, et al. Dysbiosis of the gut microbiome is associated with tumor biomarkers in lung cancer. Int J Biol Sci. 2019;15(11):2381–2392.
   PubMed Web of Science ®Google Scholar
• Yang Y, Misra BB, Liang L, et al. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer. Theranostics. 2019;9(14):4101–4114.
   PubMed Web of Science ®Google Scholar
• Villafuerte D, Aliberti S, Soni NJ, et al. Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia. Respirology. 2020;25(5):543–551.
   PubMed Web of Science ®Google Scholar
• Yoo JY, Groer M, Dutra SVO, et al. Gut microbiota and immune system interactions. Microorganisms. 2020;8(10):1587.
   PubMed Web of Science ®Google Scholar
• Cattaneo A, Cattane N, Galluzzi S, et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2017;49:60–68.
   PubMed Web of Science ®Google Scholar
• Brennan CA, Garrett WS. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium. Nat Rev Microbiol. 2019;17(3):156–166.
   PubMed Web of Science ®Google Scholar
• Parhi L, Alon-Maimon T, Sol A, et al. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat Commun. 2020;11(1):3259.
   PubMed Web of Science ®Google Scholar
• Xia X, Wu WKK, Wong SH, et al. Bacteria pathogens drive host colonic epithelial cell promoter hypermethylation of tumor suppressor genes in colorectal cancer. Microbiome. 2020;8(1):108.
   PubMed Web of Science ®Google Scholar
• Daniel SG, Ball CL, Besselsen DG, et al. Functional changes in the gut microbiome contribute to transforming growth factor β-deficient colon cancer. mSystems. 2017;2(5). DOI:10.1128/mSystems.00065-17
   PubMed Web of Science ®Google Scholar
• Hua X, Zhu J, Yang T, et al. The gut microbiota and associated metabolites are altered in sleep disorder of children with autism spectrum disorders. Front Psychiatry. 2020;11:855.
   PubMed Web of Science ®Google Scholar
• Singhal R, Donde H, Ghare S, et al. Decrease in acetyl-CoA pathway utilizing butyrate-producing bacteria is a key pathogenic feature of alcohol-induced functional gut microbial dysbiosis and development of liver disease in mice. Gut Microbes. 2021;13(1):1946367.
   PubMed Web of Science ®Google Scholar
• Chen D, Jin D, Huang S, et al. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Lett. 2020;469:456–467.
   PubMed Web of Science ®Google Scholar
• Badgeley A, Anwar H, Modi K, et al. Effect of probiotics and gut microbiota on anti-cancer drugs: mechanistic perspectives. Biochim Biophys Acta Rev Cancer. 2021;1875(1):188494.
   PubMed Web of Science ®Google Scholar
• Gkiouli M, Biechl P, Eisenreich W, et al. Diverse roads taken by (13)C-glucose-derived metabolites in breast cancer cells exposed to limiting glucose and glutamine conditions. Cells. 2019;8(10):1113.
   PubMed Web of Science ®Google Scholar
• Rajkumar-Calkins AS, Szalat R, Dreze M, et al. Functional profiling of nucleotide Excision repair in breast cancer. DNA Repair (Amst). 2019;82:102697.
   PubMed Web of Science ®Google Scholar
• Yu H, Li Y, Li L, et al. Functional reciprocity of proteins involved in mitosis and endocytosis. Febs J. 2021;288(20):5850–5866.
   PubMed Web of Science ®Google Scholar
• Liakos A, Lavigne MD, Fousteri M. Nucleotide excision repair: from neurodegeneration to cancer. Adv Exp Med Biol. 2017;1007:17–39.
   PubMed Web of Science ®Google Scholar